Format
Sort by

Send to

Choose Destination

Search Tip

Sort by Best Match to display results from highest to lowest relevance to your search terms.

Try it Now

Search results

Items: 1 to 20 of 187

1.

Perioperative Allogenic Blood Transfusion in Renal Cell Carcinoma: Risk Factors and Effect on Long-term Outcomes.

Soria F, de Martino M, Leitner CV, Moschini M, Shariat SF, Klatte T.

Clin Genitourin Cancer. 2016 Dec 29. pii: S1558-7673(16)30348-2. doi: 10.1016/j.clgc.2016.12.002. [Epub ahead of print]

PMID:
28089722
2.

Incidence and effect of variant histology on oncological outcomes in patients with bladder cancer treated with radical cystectomy.

Moschini M, Dell'Oglio P, Luciano' R, Gandaglia G, Soria F, Mattei A, Klatte T, Damiano R, Shariat SF, Salonia A, Montorsi F, Briganti A, Colombo R, Gallina A.

Urol Oncol. 2017 Jan 10. pii: S1078-1439(16)30413-6. doi: 10.1016/j.urolonc.2016.12.006. [Epub ahead of print]

PMID:
28087131
3.

The presence of carcinoma in situ at radical cystectomy increases the risk of urothelial recurrence: Implications for follow-up schemes.

Moschini M, Shariat SF, Abufaraj M, Soria F, Klatte T, Croce G, Mattei A, Damiano R, Salonia A, Montorsi F, Briganti A, Colombo R, Gallina A.

Urol Oncol. 2016 Dec 5. pii: S1078-1439(16)30369-6. doi: 10.1016/j.urolonc.2016.11.003. [Epub ahead of print]

PMID:
27932269
4.

Preoperative anemia is associated with disease recurrence and progression in patients with non-muscle-invasive bladder cancer.

Soria F, Moschini M, Abufaraj M, Wirth GJ, Foerster B, Gust KM, Özsoy M, Briganti A, Gontero P, Mathieu R, Rouprêt M, Karakiewicz PI, Shariat SF.

Urol Oncol. 2016 Nov 28. pii: S1078-1439(16)30362-3. doi: 10.1016/j.urolonc.2016.10.021. [Epub ahead of print]

PMID:
27908681
5.

Prognostic role of expression of N-cadherin in patients with upper tract urothelial carcinoma: a multi-institutional study.

Abufaraj M, Moschini M, Soria F, Gust K, Özsoy M, Mathieu R, Rouprêt M, Margulis V, Karam JA, Wood CG, Briganti A, Bensalah K, Haitel A, Shariat SF.

World J Urol. 2016 Nov 9. [Epub ahead of print]

PMID:
27830374
6.

Author Reply.

Rioja J, Soria F, Rodríguez-Rubio Cortadellas F.

Urology. 2017 Jan;99:129-130. doi: 10.1016/j.urology.2016.03.048. No abstract available.

PMID:
27816274
7.

Management of muscle invasive, locally advanced and metastatic urothelial carcinoma of the bladder: a literature review with emphasis on the role of surgery.

Abufaraj M, Gust K, Moschini M, Foerster B, Soria F, Mathieu R, Shariat SF.

Transl Androl Urol. 2016 Oct;5(5):735-744. Review.

8.

How to optimally manage elderly bladder cancer patients?

Soria F, Moschini M, Korn S, Shariat SF.

Transl Androl Urol. 2016 Oct;5(5):683-691. Review.

9.

The impact of local treatment of the primary tumor site in node positive and metastatic prostate cancer patients.

Moschini M, Soria F, Briganti A, Shariat SF.

Prostate Cancer Prostatic Dis. 2016 Oct 25. doi: 10.1038/pcan.2016.52. [Epub ahead of print] Review.

PMID:
27779202
10.

Androgen receptor expression is associated with adverse pathological features in ureteral but not in pelvicalyceal urothelial carcinomas of the upper urinary tract.

Wirth GJ, Haitel A, Moschini M, Soria F, Klatte T, Hassler MR, Bensalah K, Briganti A, Karam JA, Lotan Y, Margulis V, Raman JD, Remzi M, Rioux-Leclercq N, Robinson BD, Rouprêt M, Wood CG, Shariat SF.

World J Urol. 2016 Oct 11. [Epub ahead of print]

PMID:
27730305
11.

[Metallic ureteral stents. Present and future.]

Morcillo E, Fernández I, Pamplona M, Sánchez-Margallo FM, Soria F.

Arch Esp Urol. 2016 Oct;69(8):583-594. Spanish.

PMID:
27725334
12.

[Biodegradable catheters and urinary stents. When?]

Soria F, Morcillo E, López de Alda A, Pastor T, Sánchez-Margallo FM.

Arch Esp Urol. 2016 Oct;69(8):553-564. Spanish.

PMID:
27725331
13.

[Antirreflux ureteral catheters.]

Soria F, de la Cruz JE, Morcillo E, Rioja J, Sánchez-Margallo FM.

Arch Esp Urol. 2016 Oct;69(8):544-552. Spanish.

PMID:
27725330
14.

[Application of fluid mechanics and simulation: urinary tract and ureteral catheters.]

Gómez-Blanco JC, Martínez-Reina J, Cruz D, Blas Pagador J, Sánchez-Margallo FM, Soria F.

Arch Esp Urol. 2016 Oct;69(8):451-461. Spanish.

PMID:
27725321
15.

The surgical management of patients with clinical stage T4 bladder cancer: A single institution experience.

Moschini M, Luzzago S, Zaffuto E, Dell'Oglio P, Gandaglia G, Mattei A, Damiano R, Soria F, Klatte T, Shariat SF, Salonia A, Montorsi F, Briganti A, Gallina A, Colombo R.

Eur J Surg Oncol. 2016 Sep 28. pii: S0748-7983(16)30897-6. doi: 10.1016/j.ejso.2016.08.024. [Epub ahead of print]

PMID:
27720312
16.

The effect of HER2 status on oncological outcomes of patients with invasive bladder cancer.

Soria F, Moschini M, Haitel A, Wirth GJ, Gust KM, Briganti A, Rouprêt M, Klatte T, Hassler MR, Karakiewicz PI, Shariat SF.

Urol Oncol. 2016 Dec;34(12):533.e1-533.e10. doi: 10.1016/j.urolonc.2016.07.006.

PMID:
27665356
17.

Epidemiology, diagnosis, preoperative evaluation and prognostic assessment of upper-tract urothelial carcinoma (UTUC).

Soria F, Shariat SF, Lerner SP, Fritsche HM, Rink M, Kassouf W, Spiess PE, Lotan Y, Ye D, Fernández MI, Kikuchi E, Chade DC, Babjuk M, Grollman AP, Thalmann GN.

World J Urol. 2016 Sep 7. [Epub ahead of print]

PMID:
27604375
18.

Effect of Stage Migration on Bladder Cancer: A Slow but Steady Improvement in Long-Term Survival Rates After Radical Cystectomy in Previous 25 Years.

Moschini M, Luzzago S, Cazzaniga W, Cucchiara V, Bandini M, Damiano R, Soria F, Klatte T, Shariat SF, Salonia A, Montorsi F, Briganti A, Colombo R, Gallina A.

Clin Genitourin Cancer. 2016 Aug 8. pii: S1558-7673(16)30227-0. doi: 10.1016/j.clgc.2016.07.024. [Epub ahead of print]

PMID:
27589904
19.

Validation of Preoperative Risk Grouping of the Selection of Patients Most Likely to Benefit From Neoadjuvant Chemotherapy Before Radical Cystectomy.

Moschini M, Soria F, Klatte T, Wirth GJ, Özsoy M, Gust K, Briganti A, Roupret M, Susani M, Haitel A, Shariat SF.

Clin Genitourin Cancer. 2016 Jul 22. pii: S1558-7673(16)30217-8. doi: 10.1016/j.clgc.2016.07.014. [Epub ahead of print]

PMID:
27530435
20.

HER2 overexpression is associated with worse outcomes in patients with upper tract urothelial carcinoma (UTUC).

Soria F, Moschini M, Haitel A, Wirth GJ, Karam JA, Wood CG, Rouprêt M, Margulis V, Karakiewicz PI, Briganti A, Raman JD, Kammerer-Jacquet SF, Mathieu R, Bensalah K, Lotan Y, Özsoy M, Remzi M, Gust KM, Shariat SF.

World J Urol. 2016 Jun 7. [Epub ahead of print]

PMID:
27272502
Items per page

Supplemental Content

Loading ...
Support Center